Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionLaraway Financial Inc
Latest Disclosed Ownership7,606 shares
Latest Disclosed Value $ 279,521
Laraway Financial Inc reports 5.00% decrease in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 14, 2026 - Laraway Financial Inc filed a 13F-HR form disclosing ownership of 7,606 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $239,969 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 8,006 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -5.00% during the quarter. The current value of the position is $272,447 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 7,606 -400 -5.00 280 -31.45 0.1965
2026-02-13 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 8,006 0 0.00 407 -8.33 0.2654
2025-11-14 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 8,006 600 8.10 444 -13.11 0.3033
2025-07-23 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 7,406 0 0.00 511 -0.58 0.3877
2025-05-14 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 7,406 0 0.00 514 -19.31 0.4086
2025-02-14 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 7,406 0 0.00 637 -27.70 0.4908
2024-11-15 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 7,406 0 0.00 882 -16.65 0.7032
2024-08-13 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 7,406 0 0.00 1,057 11.26 0.9030
2024-05-14 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 7,406 50 0.68 951 25.00 0.8386
2024-02-07 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 7,356 -300 -3.92 761 9.20 0.7229
2023-11-16 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 7,656 3,628 90.07 696 6.91 0.7253
2023-07-28 2023-06-30 13F NOVO-NORDISK A S ADR 670100205 4,028 -300 -6.93 652 -5.38 0.6445
2023-06-09 2023-03-31 13F NOVO-NORDISK A S ADR 670100205 4,328 4,328 689 0.6979
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.